The Role of Nutraceuticals in Degenerative Diseases (Part 2)

Nutraceuticals are natural food-derived components that provide additional health benefits and potentially reduce cardiovascular disease (CVD) risk factors, such as hypertension, arrhythmia, myocardial infarction, hypertrophy, and atherosclerosis.

The objective of this book chapter is to explore the underlying mechanisms and provide a thorough assessment of the effects and benefits of nutraceuticals, such as garlic, grapes, ginger, turmeric, onion, blueberry, apple, brassica, tulsi, papaya, spirulina, etc.

Dietary habits have an immense effect on cardiovascular health. It has been established that nutraceuticals target various pathways involved in the evolution of CVD and offer a comprehensive approach for treating and preventing CVD. Studies show that consumption of nutraceuticals, such as omega-3 fatty acids, garlic, and dietary fibres in the diet, can improve cardiovascular risk factors, such as hypertension and hyperlipidemia, by reducing blood pressure and lipid profile levels. More specifically, it has been demonstrated that nutraceuticals like grapes, turmeric, and omega-3 fatty acids exhibit anti-inflammatory and anti-oxidation characteristics vital for healthy human blood vessels and arteries. However, these promising results have been achieved through heterogeneous study designs and therefore require further research regarding the applications of nutraceuticals in clinical practice.

In conclusion, nutraceuticals show an attractive emerging field in treating CVD. When combined with traditional therapies, nutraceuticals can play a supportive role by mitigating risk factors while improving treatment outcomes, thereby serving as an essential component of extensive cardiovascular treatment. Future research is needed to better understand the effects and potential of nutraceuticals in improving cardiovascular health.

Arthritis refers to joint pain, inflammation, or joint disease. It is the most common cause of disability, affecting people of all ages, races, and genders. In most cases, women are more commonly affected, and symptoms may worsen over time. Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by inflammatory arthritis and extra-articular involvement. It typically starts in small peripheral joints, is usually symmetric, and may progress to involve proximal joints if left untreated. Joint inflammation over time can lead to the destruction of the joint, resulting in loss of cartilage and bone erosion. Osteoarthritis (OA) is a chronic autoimmune disease that primarily targets the lining of synovial joints, leading to progressive disability, early mortality, and socioeconomic challenges. The pathogenesis of OA presents a multifaceted landscape, involving diverse etiologies and intricate molecular and cellular mechanisms. OA manifests as functional impairment of the joint, characterized by alterations in joint morphology resulting from the erosion of articular cartilage, the formation of osteophytes, subchondral sclerosis, bone marrow lesions (BMLs), and synovial proliferation. The role of chondroitin sulfate (CS) biosynthesis in OA is highlighted, with altered CS chain length correlating with disease severity. Nutraceuticals have been shown to be effective in the management of both OA and RA by acting as anti-inflammatory agents, primarily through the inhibition of the tumor necrosis factor (TNF) catabolic signaling pathway in chondrocytes. In this chapter, we discuss the effectiveness, safety, and toxicity of nutraceutical products in the treatment of RA and OA.

In recent years, emerging evidence suggests that nutraceuticals, due to their variety and multifaceted therapeutic impacts, may be a distinct and complementary prophylactic option for diabetes and its complications. Several nutraceuticals, including vitamin C, α-lipoic acid, L-carnitine, co-enzyme Q10, and others, have shown antidiabetic properties over the years. In this chapter, we look at the possible benefits of nutraceuticals against this metabolic disorder and relevant complications. According to several pre-clinical and clinical studies, nutraceuticals can alter the metabolism of lipids and carbohydrates, induce hypoglycaemic effects, reduce insulin resistance and dyslipidaemia, improve lipolysis in adipose tissues, reduce free radical damage, stresssensitive cascades, and mitigate inflammatory responses. Nutraceuticals can also help in the prevention of chronic diabetic consequences, including cardiovascular complications, nephropathy, CNS ailments, and retinopathy. In summary, the role of nutraceuticals in diabetes treatment is rapidly expanding, with a wide range of bioactive compounds supporting diabetic care through multiple pathways. The advantages of these products include better glycaemic control, enhanced insulin sensitivity, and fewer complications from diabetes. Nutraceuticals are expected to become more significant in the treatment of diabetes as scientific knowledge advances. They offer a holistic approach that empowers people through lifestyle modifications aimed at enhancing long-term health outcomes in addition to supplemental medication therapy. Further research, focusing on clinical utilization, is required to determine nutraceutical supplementation in diabetic patients. 

Nutraceuticals, derived from food sources, offer additional health benefits beyond basic nutrition. Combining “nutrient” and “pharmaceutical,” nutraceuticals are increasingly recognized for their potential in managing various diseases, particularly ocular disorders, without the side effects often associated with synthetic pharmaceuticals. These natural compounds contribute to vital biological processes, including antioxidant defence and cellular integrity, thereby enhancing health, preventing chronic diseases, and potentially extending life expectancy. With various forms available, such as pills, powders etc., nutraceuticals are easily accessible and cost-effective. In the realm of neurodegenerative diseases, nutraceuticals can play a significant role in mitigating conditions affecting vision, including age-related macular degeneration (AMD), diabetic retinopathy (DR), and glaucoma. These disorders are often linked to oxidative stress, wherein reactive oxygen species (ROS) contribute to retinal ganglion cell degeneration. Nutraceuticals with antioxidant properties have been shown to reduce ROS levels, thereby offering a protective effect against ocular degeneration. This chapter briefly focuses on the pathophysiology of common degenerative eye diseases and discusses the potential of nutraceuticals in their prevention and management. By enhancing nutritional intake without altering physiological states, nutraceuticals present a compelling alternative to conventional drugs, particularly for age-related vision disorders, promoting overall ocular health and potentially reducing the prevalence of vision impairment in aging populations.

Nutraceuticals are employed to improve health, offering physiological benefits alongside their nutritional value. Nutraceuticals can support the normal functioning of the human body, prevent certain diseases, and slow down the aging process. The edible nature, absence of adverse effects, and excellent in vivo compatibility have made nutraceuticals an excellent alternative to available marketed dosage forms. Recently, liver disorders have emerged as one of the major issues due to an unhealthy lifestyle. The over-consumption of medicines can also affect the healthy liver. Nutraceuticals can be an alternative and effective option for preventing and managing liver diseases. Several nutraceuticals are reported to be effective against different liver disorders, including hepatitis, non-alcoholic fatty liver disease, alcoholic fatty liver disease, liver cirrhosis, hepatocellular carcinoma, etc. The most commonly applied nutraceuticals in the treatment of several liver disorders include silymarin, Omega-3 fatty acids, curcumin, liquorice root, vitamin E, berberine, ginseng, beetroot, and probiotics. These nutraceuticals have shown considerable efficacy in the therapy of various liver diseases. The beneficial effects of nutraceuticals can surely encourage their use in the prevention and therapy of hepatic disorders. However, further randomized controlled studies are required to establish the direct effect of nutraceuticals on liver diseases with histological changes. This chapter provides a detailed insight into various liver disorders, including their pathogenesis and diagnosis. Additionally, it describes various nutraceuticals, along with their sources and the beneficial effects they have on several liver diseases.

Degenerative muscle diseases are commonly known as neuromuscular disorders where degeneration and progressive weakness are observed in the muscles due to genetic disorders or mutations. Degenerative muscle diseases are caused by a variety of factors, including autoimmune disorders, genetic mutations, metabolic abnormalities, and environmental influences. Among the genetic factors, Duchenne muscular dystrophy, Becker muscular dystrophy, and spinal muscular atrophy are commonly observed, which mostly affect humans of all age groups. Autoimmune responses cause rare inflammatory diseases, polymyositis and dermatomyositis, causing muscle weakness and a distinctive skin rash. There is currently no approved cure for degenerative muscle diseases. Still, treatments such as a combination of corticosteroids and immunosuppressive drugs, physical therapy, and other supportive approaches are commonly used to help muscle function, strength, manage complicated symptoms, and improve quality of life. However, the clinical trial of several drugs (rimeporide and alendronate for Duchenne muscular dystrophy) has been going on. Nutraceuticals, naturally present in food, are dietary supplements that are thought to provide both nutrition and medicinal benefits. Although nutraceuticals cannot correct the genetic abnormalities underlying muscular dystrophy, they can provide additional benefits like maintenance of bone health, muscle hypertrophy, protection against muscle damage, and reduction in inflammation and oxidative stress in muscle tissues. Some nutraceuticals used in neuromuscular disorders are omega-3 fatty acids, vitamins C, D, and E, amino acid derivatives, etc. Nutraceuticals and their supplements can regenerate, repair, and remodel the injured tissue by increasing and improving the growth of muscle tissue. The chapter focuses on the current scenario of the different types of degenerative muscle diseases and the role of nutrients in these types of diseases.

Degenerative disc disease (DDD) is a common condition affecting the intervertebral disc and vertebral bodies, particularly in the lumbar spine, and it is often diagnosed in early to middle age. Osteoblasts and osteoclasts play a crucial role in bone remodeling, which preserves metabolic balance and skeletal integrity. After the old or injured bone has been reabsorbed, new bone material is deposited. Osteocytes regulate bone formation, collagen breakdown, hormonal signals, mechanical strain, and remodeling site and timing. A reduction in bone density may result from imbalances. Commonly, it is associated with various factors, such as genetics, obesity, diabetes, smoking, physical strain, discogenic pain, and gene polymorphisms. Modern medical technologies can help identify encouraging variables to prevent DDD. However, many people do not receive early diagnosis and treatment. Hence, understanding the underlying cellular mechanisms of the inflammatory response can significantly enhance the prevention and treatment of DDD. Additionally, lifestyle modifications like maintaining a healthy diet, exercising regularly, quitting smoking and alcohol, and monitoring DDD-promoting variables can help reduce its incidence. As a consequence of their anti-inflammatory and antioxidant qualities, phytoconstituents produced from plants have drawn interest for their possible therapeutic function in DDD. The significance and utilization of nutraceuticals, pharmaceuticals, and supplements to enhance bone health in DDD patients are highlighted in this chapter.